It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and regulatory updates were in focus. Recap of the Week’s ...
This second of a three-part series, on the availability of pangolin-based traditional Chinese medicines in the market despite ...
Zacks.com on MSN13h
Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDAIt was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback